Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Eleanor Manners

The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-Risk Neuroblastoma Independent of MYCN Status

Nature Communications

Molecular Biology

English

Related publications

The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma in Vivo

Molecular Cancer Therapeutics

Cancer Research

English

Impact of MYCN Status on Response of High-Risk Neuroblastoma to Neoadjuvant Chemotherapy

Journal of Pediatric Surgery

English

The ALK Inhibitor PF-06463922 Is Effective as a Single Agent in Neuroblastoma Driven by Expression of ALK and MYCN

DMM Disease Models and Mechanisms

Molecular Biology

English

MYCN Controls an Alternative RNA Splicing Program in High-Risk Metastatic Neuroblastoma

Cancer Research

English

PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells

Cancer Research

Cancer Research

English

Aberrant Activation of ALK Kinase by a Novel Truncated Form ALK Protein in Neuroblastoma

Cancer Research

Molecular Biology

English

Inhibition of Autophagy Potentiates the Efficacy of Gli Inhibitor GANT-61 in MYCN-amplified Neuroblastoma Cells

Cancer Research

English

Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma

English

Ataxia-Telangiectasia Mutated (ATM) Silencing Promotes Neuroblastoma Progression Through a MYCN Independent Mechanism

English